NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: Eckert & Ziegler's Participation in the 44th Annual J.P. Morgan Healthcare Conference
TL;DR
Eckert & Ziegler's participation in the J.P. Morgan Healthcare Conference offers investors a strategic opportunity to gain insights into the company's growth plans in the radiopharmaceutical sector.
Eckert & Ziegler will present at the conference on January 14, 2026, with a livestream available on their website and a recording accessible for 30 days afterward.
Eckert & Ziegler's work in nuclear medicine and radiation therapy contributes to saving lives by advancing treatments for serious medical conditions.
A leading isotope specialist with over 1,000 employees will share its vision at a major healthcare conference, accessible worldwide via livestream.
Found this article helpful?
Share it with your network and spread the knowledge!
The announcement covers Eckert & Ziegler SE's participation in the 44th Annual J.P. Morgan Healthcare Conference, including details about the presentation by their CEO.
The conference is on Wednesday, 14 January 2026, at the Westin St. Francis in San Francisco, CA, USA.
Dr. Harald Hasselmann, CEO of Eckert & Ziegler SE, will present the company at 17:15 PST.
The presentation will be available as an audio livestream on the company's website at https://www.ezag.com/investors/presentations/.
Yes, the recording will be available on the company's website for approximately 30 days after the event.
Eckert & Ziegler SE is a leading specialist for isotope-related components in nuclear medicine and radiation therapy, offering services and products for the radiopharmaceutical industry from development to manufacturing and distribution.
The company is headquartered at Robert-Rössle-Str. 10, 13125 Berlin, Germany. For investor relations, contact Karolin Riehle at +49 (0) 30 / 94 10 84-138 or karolin.riehle@ezag.de.
Participation in this major healthcare conference allows the company to present its role in nuclear medicine and radiation therapy, highlighting its contributions to saving lives through isotope-related technologies.
Curated from NewMediaWire
